Surprised by the FY17Q2 cash receipts and wonder whether this was due to collections for a stellar FY17Q1. In any case, consecutive quarters of positive cashflow show we're heading in the right direction financially.
The improved financing arrangement represents a nod of approval from bankers, which is a plus.
"This stronger result is anticipated to continue into Q2FY17" from their 30 September 2016 commentary has occurred, which is also a plus. "As a result the outlook for growth in the year ahead remains very positive" from their 31 December 2016 commentary is something to come back to at the subsequent quarters.
Would prefer the interest to drop of a little, so I can fill the gap. But maybe the cat is out of the bag already.
$000 Sep-15 Dec-15 Mar-16 Jun-16 Sep-16 Dec-16 1 Receipts 6,556 5,076 7,169 6,053 9,562 9,674 2 NOCF (184) (503) 1,908 (1,289) 527 586
- Forums
- ASX - By Stock
- Ann: Change of Director's Interest Notice
SEQ
sequoia financial group ltd
Add to My Watchlist
1.43%
!
35.5¢

Surprised by the FY17Q2 cash receipts and wonder whether this...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $43.87M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 35.0¢ | $37.20K | 105.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56039 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 19052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50325 | 0.350 |
1 | 2944 | 0.340 |
1 | 2982 | 0.335 |
1 | 3000 | 0.330 |
2 | 69535 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 19052 | 2 |
0.360 | 134902 | 2 |
0.365 | 72540 | 3 |
0.370 | 33513 | 2 |
0.375 | 89000 | 3 |
Last trade - 15.00pm 27/06/2025 (20 minute delay) ? |
Featured News
SEQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online